Human papillomavirus vaccine acceptability among a national sample of adult women in the USA.

Abstract

BACKGROUND In the USA, the human papillomavirus (HPV) vaccine is currently licensed for 9-26-year-old females, but licensure for women over 26 years is being considered. The aim of the current study was to investigate the association of sociodemographic and health-related factors to HPV vaccine acceptability among adult women. METHODS The current study… (More)
DOI: 10.1071/SH09127

Topics

Cite this paper

@article{Stupiansky2010HumanPV, title={Human papillomavirus vaccine acceptability among a national sample of adult women in the USA.}, author={Nathan W. Stupiansky and Susan L. Rosenthal and Sarah Wiehe and Gregory D. Zimet}, journal={Sexual health}, year={2010}, volume={7 3}, pages={304-9} }